EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi‐Omics Profiling and Experimental Verification of Lysosomes‐Related Genes in Hepatocellular Carcinoma

Zhiyong Wang iD, Guoliang Wang, Peng Zhao, Ping Sun

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Zhiyong Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lysosomes, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosomes play a crucial role in regulating the growth, invasion and metastasis of different tumour types. However, the specific function of lysosomes in hepatocellular carcinoma (HCC) remains uncertain. We retrieved gene expression and clinical data from the TCGA and GEO databases for HCC samples and established a new lysosome‐associated prognostic therapeutic index (LAPTI) based on lysosome‐related genes through machine learning. We then systematically analysed clinical characteristics, functional enrichment, tumour immune microenvironment, molecular docking, chemotherapy response and immunotherapy response in HCC. LAPTI, composed of four lysosome‐related genes (CTSV, LAPTM4B, DNAJC6, AP1M2), is a reliable prognostic indicator for hepatocellular carcinoma patients and is validated in external data sets. Compared with the low LAPTI group, the high LAPTI group showed poorer prognosis and higher immune cell infiltration levels. We also observed that knocking down CTSV in vitro inhibited the proliferation and migration of hepatocellular carcinoma. This study provides valuable insights into the future clinical treatment of hepatocellular carcinoma by accurately assessing the prognosis of patients with hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLysosomesGene Expression Regulation, NeoplasticTumor MicroenvironmentHumansPrognosisCell ProliferationGene Expression ProfilingBiomarkers, TumorCell MovementCell Line, TumorMolecular Docking SimulationComputational BiologyMultiomics

Stichwörter der Autor:innen

CTSVhepatocellular carcinomaimmunotherapy efficacylysosomesmolecular dockingprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Zhiyong Wang

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Wang, G., Zhao, P., & Sun, P. (2024). Multi‐Omics Profiling and Experimental Verification of Lysosomes‐Related Genes in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70225

Vancouver

Wang Z, Wang G, Zhao P, Sun P. Multi‐Omics Profiling and Experimental Verification of Lysosomes‐Related Genes in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70225

BibTeX
@article{Wang2024,
  author = {Wang, Zhiyong and Wang, Guoliang and Zhao, Peng and Sun, Ping},
  title = {Multi‐Omics Profiling and Experimental Verification of Lysosomes‐Related Genes in Hepatocellular Carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70225}
}
Kostenlos starten →